Predicting nerve damage with blood markers
Part of Brain & nervous system clinical trials.
This study looks at certain markers in the blood that may help predict how polyneuropathy (nerve damage) will progress. It involves physical tests, and results could help doctors better understand the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with polyneuropathy (nerve damage that causes numbness, tingling, or weakness) and it was confirmed with a nerve test called a nerve conduction study.
- You can read and understand Danish.
- You do not have any other health problems that would make it hard to do physical tests, unless those problems are not related to your polyneuropathy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how polyneuropathy (nerve damage) affects your daily physical activity and overall function. It aims to understand the link between nerve damage and movement, which could help improve care.
This study looks at genetic differences in people being checked for a common type of nerve problem called distal symmetric polyneuropathy (nerve damage that usually affects the hands and feet). By understanding genetics, researchers hope to learn more about why neuropathic (nerve) pain happens and how it may differ between people.
This study is looking at whether a protein in the blood called 'irisin' can be a sign of diabetic nerve damage. If you have type 2 diabetes and nerve symptoms, this research might help find a simple blood test to detect or monitor the condition.
This study uses ultrasound to look at nerves in people with a nerve condition called polyneuropathy that isn't caused by something else. It aims to see if ultrasound can help doctors diagnose this condition better.
This study looks at how age affects a specific nerve test used to diagnose peripheral neuropathy. It uses a special ratio comparing sensation in your foot (sural nerve) to your thumb (radial nerve) to see if it works equally well in younger and older adults.
This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.
Hear when a new Polyneuropathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.